October 2021

Mayeta Clark 2015

Opening the policy blackbox: unravelling the process for changing national diagnostic and treatment guidelines for vivax malaria in seven countries

October 30, 2021

Background: The changing global health landscape has highlighted the need for more proactive, efficient and transparent health policy-making. After more than…

Read More

Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial

October 25, 2021

Background: There is a high risk of Plasmodium vivax recurrence in patients treated for Plasmodium falciparum malaria in co-endemic areas. Primaquine…

Read More